Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
Dr Saeed Al-Shomimi KFHU Khobar
Anatomy <ul><li>6 – 8 cm  </li></ul><ul><li>Splenic + s. mesenteric  </li></ul><ul><li>(behind neck of the pancreas ) </li...
Blood Supply of the Liver Hepatic Arterial Autoregularity Vasodilatation
Pathophysiology <ul><li>Pressure = Flow X Resistance </li></ul><ul><li>Portal pressure : 3 – 6 mm Hg </li></ul><ul><li>Nor...
<ul><li>10 mmHg (prolonged) -> Shunting </li></ul><ul><ul><li>Lt Gastric -> esophageal </li></ul></ul><ul><ul><li>Short Ga...
Causes of Portal Hypertension Pre-sinusoidal Sinusoidal Post Sinusoidal BLOOD FLOW LIVER
<ul><li>Pre-sinusoidal </li></ul><ul><ul><li>Extra-hepatic: </li></ul></ul><ul><ul><ul><li>Portal vein thrombosis </li></u...
<ul><li>Sinusoidal </li></ul><ul><ul><li>Steatohepatits </li></ul></ul><ul><ul><li>Wilson disease </li></ul></ul>
<ul><li>Post Sinusoidal </li></ul><ul><ul><li>Extra-hepatic: </li></ul></ul><ul><ul><ul><li>Budd Chiari syndrome </li></ul...
Variceal Bleeding <ul><li>Mortality associated with 1 st  episode: </li></ul><ul><ul><li>Cirrhotic patient  :  40% - 70% <...
Acute Variceal Bleeding
Initial evaluation & stabilization <ul><li>Assessment of intravascular volume status </li></ul><ul><li>Fluid resuscitation...
Pharmacologic Radiologic shunt TIPSS Surgical Shunt Balloon  Tamponade Pharmacologic and endoscopic therapy are the usual ...
Pharmacologic Therapy <ul><li>Octreotide </li></ul><ul><ul><li>Synthetic analogue of somatostatin </li></ul></ul><ul><ul><...
<ul><ul><li>5-day course reduces bleeding after endoscopic therapy  </li></ul></ul><ul><ul><li>Can cause mild hyperglycemi...
<ul><li>Vasopressin </li></ul><ul><ul><li>Reduces portal pressure but causes myocardial and mesenteric ischemia (more side...
<ul><li>Terlipressin </li></ul><ul><ul><li>Efficacy similar to endoscopic sclerotherapy and as effective as balloon tampon...
Endoscopic Therapy <ul><li>Sclerosant injection </li></ul><ul><li>Band ligation </li></ul><ul><li>Became a standard form o...
sclerotherapy <ul><li>5% sodium morrhuate </li></ul><ul><li>5% ethanolamine oleate </li></ul><ul><li>Intravariceally : to ...
<ul><li>3 prospective randomized controlled trials studies comparing sclerotherapy and balloon temponade: </li></ul><ul><u...
<ul><li>Complications: </li></ul><ul><ul><li>Pulmonary complications </li></ul></ul><ul><ul><li>Transient chest pain </li>...
<ul><li>Alternative to sclerotherapy </li></ul><ul><li>Fewer rebleeding episodes </li></ul><ul><li>Fewer endoscopic interv...
Pharmacologic versus Endoscopic Therapy <ul><li>2 meta-analysis compared medical pharmacotherapy with emergency sclerother...
Balloon Temponade <ul><li>Application of direct upward pressure against varices at G-E junction </li></ul><ul><li>Should b...
Balloon positioning
<ul><ul><li>1. Tube inserted to 50 cm </li></ul></ul><ul><ul><li>2. Auscultate in stomach  </li></ul></ul><ul><ul><li>3. I...
<ul><li>Esophageal Balloon inflated to  35 - 40  mmHg </li></ul><ul><li>Last resort </li></ul><ul><li>Deflate periodically...
<ul><li>Direct temponade therapy is 90% effective in controlling the bleeding </li></ul><ul><li>50%  rebleeding after remo...
TIPS (Transjagular Intrahepatic Portosystemic Shunting) <ul><li>Creating an intrahepatic portosystemic fistula to decompre...
<ul><li>1 -Cannulating the Rt hepatic vein via internal jagular vein </li></ul><ul><li>2 – passing needle through liver pa...
<ul><li>5 – stenting the tract </li></ul>
 
<ul><li>Meta-analysis comparing TIPS with endoscopy in acute hge: </li></ul><ul><ul><li>Significant improvement in control...
<ul><li>Contraindications: </li></ul><ul><ul><li>R side heart failure </li></ul></ul><ul><ul><li>Polycystic liver </li></u...
<ul><li>Complications: </li></ul><ul><ul><li>Intraperitoneal bleeding due to perforation of the hepatic capsule, hepatic, ...
<ul><li>Late: </li></ul><ul><ul><li>recurrent bleeding due to TIPS stenosis or thrombosis </li></ul></ul><ul><ul><li>Infec...
Surgical Therapy <ul><li>Operative intervention is reserved for cases  refractory  to other modalities </li></ul>
<ul><li>Esophageal transection EEA stapler </li></ul><ul><ul><li>Operative mortality 75% </li></ul></ul><ul><ul><li>Compli...
<ul><li>Portosystemic Shunt (side-to-side) </li></ul><ul><ul><li>Non-selective shunt </li></ul></ul><ul><ul><li>Manipulati...
<ul><li>DSRS </li></ul><ul><ul><li>Selective shunt </li></ul></ul><ul><ul><li>Some cases un accompanied by refractory asci...
Prevention of Recurrent Variceal Bleeding
<ul><li>Pharmacotherapy: </li></ul><ul><ul><li>Rebleeding without treatment  70%  in 1 year </li></ul></ul><ul><ul><li>Non...
<ul><li>Endoscopic therapy: </li></ul><ul><ul><li>Advocated as a means for complete eradication of esophageal varices </li...
<ul><li>TIPS: </li></ul><ul><ul><li>Bridge therapy -> liver transplant </li></ul></ul><ul><li>Advantiges over surgery: </l...
<ul><li>Surgical Therapy: </li></ul><ul><ul><li>Most effective method in controlling portal hypertension and recurrent ble...
Portosystemic Shunt <ul><li>Decompressing the hypertensive portal Venus system into the low pressure systemic venous circu...
<ul><li>To minimize these effects shunting operations have evolved: </li></ul><ul><ul><li>Non-selective </li></ul></ul><ul...
1 – Non selective Shunts <ul><li>End to side portocaval (Eck fistula): </li></ul><ul><ul><li>Higher rate of encephalopathy...
<ul><li>Side to Side portocaval shunt: </li></ul><ul><ul><li>Maintain the anatomic continuity of the portal vein </li></ul...
<ul><li>Interposition Mesocaval Shunt: </li></ul><ul><ul><li>Prosthetic – autogennous vien </li></ul></ul><ul><ul><li>Avoi...
<ul><li>Proximal Spleno-Renal Shunt: </li></ul><ul><ul><li>Splenectomy + anastomosing proximal Splenic vein to Lt Renal ve...
2 – Selective Shunts <ul><li>In response to post-op complications of non-selective procedures </li></ul><ul><li>1967 DSRS ...
<ul><li>Contraindications: </li></ul><ul><ul><li>Refractory ascitis </li></ul></ul><ul><ul><li>Splenic vein thrombosis </l...
<ul><li>Coronary – Caval Shunt: </li></ul><ul><ul><li>Described in Japan in 1984 </li></ul></ul><ul><ul><li>Interposition ...
3 – Partial Shunts <ul><li>Small diameter interposition grafts </li></ul><ul><li>Maintaining a degree of hepatopedal porta...
Esophagogastric Devascularization <ul><li>The most effective non-shunt operation for preventing variceal bleeding: </li></...
Orthotopic Liver Transplantation <ul><li>The most definitive form of therapy for complications of portal hypertension </li...
<ul><li>Child A – mild B -> non-transplant surgery </li></ul><ul><li>Child C – advanced B -> transplant </li></ul>
Prophylaxis
<ul><li>Likehood of variceal bleeding : </li></ul><ul><ul><li>Alcoholic cirrhosis </li></ul></ul><ul><ul><li>Active alcoho...
<ul><li>Non selective B blockers </li></ul><ul><li>Prophylactic shunts showed no benefit , ↑morbidity </li></ul>
<ul><li>Portal hypertension in north Indian children </li></ul><ul><li>Arora NK, Lodha R, Gulati S, Gupta AK, Mathur P, Jo...
<ul><li>cross-sectional observational study </li></ul><ul><li>Tertiary care centre in northern India </li></ul><ul><li>Jan...
<ul><li>115   patients with portal hypertension </li></ul><ul><ul><li>76.5%  had extrahepatic portal hypertension (EHPH) <...
<ul><li>Results: </li></ul><ul><ul><li>Children with  EHPH  had a significantly  earlier  onset of symptoms as compared to...
<ul><li>History suggestive of potential etiological factors could be elicited in only  7%  of EHPH patients . </li></ul><u...
<ul><li>An  inverse  relation of bleeding rates with duration of illness was seen in EHPH </li></ul>
<ul><li>Conclusion: </li></ul><ul><ul><li>Understanding the natural history of EHPH and portal hypertension due to other e...
<ul><li>References </li></ul><ul><ul><li>ACS Surgery : Principles and Practice 2004 Web,MD </li></ul></ul><ul><ul><li>Schw...
<ul><li>Thank You </li></ul>
Upcoming SlideShare
Loading in …5
×

Portal Hypertension

50,053 views

Published on

Published in: Health & Medicine
  • Be the first to comment

Portal Hypertension

  1. 1. Dr Saeed Al-Shomimi KFHU Khobar
  2. 2. Anatomy <ul><li>6 – 8 cm </li></ul><ul><li>Splenic + s. mesenteric </li></ul><ul><li>(behind neck of the pancreas ) </li></ul><ul><li>i. mesenteric , Lt gastric </li></ul>
  3. 3. Blood Supply of the Liver Hepatic Arterial Autoregularity Vasodilatation
  4. 4. Pathophysiology <ul><li>Pressure = Flow X Resistance </li></ul><ul><li>Portal pressure : 3 – 6 mm Hg </li></ul><ul><li>Normal elevation: </li></ul><ul><ul><li>Eating </li></ul></ul><ul><ul><li>Exercise </li></ul></ul><ul><ul><li>Valsalva </li></ul></ul>
  5. 5. <ul><li>10 mmHg (prolonged) -> Shunting </li></ul><ul><ul><li>Lt Gastric -> esophageal </li></ul></ul><ul><ul><li>Short Gastric -> Gastric Submucosal </li></ul></ul><ul><ul><li>Lt portal -> epigastric </li></ul></ul><ul><ul><li>Retroperetoneal and anorectal collateral </li></ul></ul><ul><li>12 mm Hg -> Bleeding </li></ul>
  6. 6. Causes of Portal Hypertension Pre-sinusoidal Sinusoidal Post Sinusoidal BLOOD FLOW LIVER
  7. 7. <ul><li>Pre-sinusoidal </li></ul><ul><ul><li>Extra-hepatic: </li></ul></ul><ul><ul><ul><li>Portal vein thrombosis </li></ul></ul></ul><ul><ul><ul><li>Splenic vein Thrombosis </li></ul></ul></ul><ul><ul><li>Intra-hepatic: </li></ul></ul><ul><ul><ul><li>Congenital hepatic fibrosis </li></ul></ul></ul><ul><ul><ul><li>Primary biliary cirrhosis </li></ul></ul></ul><ul><ul><ul><li>Sarcidosis </li></ul></ul></ul><ul><ul><ul><li>Schistosomaisis </li></ul></ul></ul>
  8. 8. <ul><li>Sinusoidal </li></ul><ul><ul><li>Steatohepatits </li></ul></ul><ul><ul><li>Wilson disease </li></ul></ul>
  9. 9. <ul><li>Post Sinusoidal </li></ul><ul><ul><li>Extra-hepatic: </li></ul></ul><ul><ul><ul><li>Budd Chiari syndrome </li></ul></ul></ul><ul><ul><ul><li>R heart Failure </li></ul></ul></ul><ul><ul><li>Intra-hepatic: </li></ul></ul><ul><ul><ul><li>Heamochromatosis </li></ul></ul></ul><ul><ul><ul><li>Alcoholic cirrhosis </li></ul></ul></ul><ul><ul><ul><li>Post-hepatitic cirrhosis </li></ul></ul></ul>
  10. 10. Variceal Bleeding <ul><li>Mortality associated with 1 st episode: </li></ul><ul><ul><li>Cirrhotic patient : 40% - 70% </li></ul></ul><ul><ul><li>Non cirrhotic : 5% - 10% </li></ul></ul><ul><li>If bleeding resolved spontaneously </li></ul><ul><ul><li>30% re-bleed , 6 weeks </li></ul></ul><ul><ul><li>70% re-bleed , 1 year </li></ul></ul><ul><li>(30% of the initial bleeding episodes are fatal) </li></ul>
  11. 11. Acute Variceal Bleeding
  12. 12. Initial evaluation & stabilization <ul><li>Assessment of intravascular volume status </li></ul><ul><li>Fluid resuscitation </li></ul><ul><li>Endotracheal intubation prior to endoscopy for: </li></ul><ul><ul><li>Uncontrolled bleeding </li></ul></ul><ul><ul><li>Altered mental status, severe agitation </li></ul></ul><ul><ul><li>Respiratory distress or depression </li></ul></ul>
  13. 13. Pharmacologic Radiologic shunt TIPSS Surgical Shunt Balloon Tamponade Pharmacologic and endoscopic therapy are the usual 1 st and 2 nd interventions Endoscopic Treatment for Acute Variceal Bleeding
  14. 14. Pharmacologic Therapy <ul><li>Octreotide </li></ul><ul><ul><li>Synthetic analogue of somatostatin </li></ul></ul><ul><ul><li>Decreases portal pressure and azygos blood flow </li></ul></ul><ul><ul><li>Stops variceal bleed in 80% of the cases </li></ul></ul><ul><ul><li>Efficacy is similar to endoscopic sclerotherapy and better than vasopressin </li></ul></ul>
  15. 15. <ul><ul><li>5-day course reduces bleeding after endoscopic therapy </li></ul></ul><ul><ul><li>Can cause mild hyperglycemia and abdominal cramping </li></ul></ul><ul><ul><li>250 µg Iv Bolus – followed by infusion 25 – 50 µg/h (2-4 days) </li></ul></ul>
  16. 16. <ul><li>Vasopressin </li></ul><ul><ul><li>Reduces portal pressure but causes myocardial and mesenteric ischemia (more side effects) </li></ul></ul><ul><ul><li>20 u IV bolus (over 20 min) – infusion 0.2 – 0.4 u/min </li></ul></ul><ul><ul><li>Control approximately 50% of acute episodes </li></ul></ul>
  17. 17. <ul><li>Terlipressin </li></ul><ul><ul><li>Efficacy similar to endoscopic sclerotherapy and as effective as balloon tamponade when used with nitroglycerin </li></ul></ul><ul><ul><li>Not approved for use in U.S. </li></ul></ul>
  18. 18. Endoscopic Therapy <ul><li>Sclerosant injection </li></ul><ul><li>Band ligation </li></ul><ul><li>Became a standard form of therapy in acute variceal bleeding </li></ul><ul><li>Initial control of hge in 70 – 95% </li></ul><ul><li>Re-bleeding 20 – 50% </li></ul>
  19. 19. sclerotherapy <ul><li>5% sodium morrhuate </li></ul><ul><li>5% ethanolamine oleate </li></ul><ul><li>Intravariceally : to obliterate the varix </li></ul><ul><li>Paravariceally : induce submucus fibrosis </li></ul>
  20. 20. <ul><li>3 prospective randomized controlled trials studies comparing sclerotherapy and balloon temponade: </li></ul><ul><ul><li>Sclerotherapy achieved better initial hge control </li></ul></ul><ul><ul><li>Fewer episodes of rebleeding </li></ul></ul><ul><ul><li>Improved long-term survival </li></ul></ul><ul><li>(furthermore, routine use of balloon temponade after sclerotherapy confer no additional benefit) </li></ul>
  21. 21. <ul><li>Complications: </li></ul><ul><ul><li>Pulmonary complications </li></ul></ul><ul><ul><li>Transient chest pain </li></ul></ul><ul><ul><li>Esophageal stricture </li></ul></ul><ul><ul><li>Portal vein thrombosis </li></ul></ul><ul><ul><li>Esophageal perforation </li></ul></ul><ul><ul><li>Bacteremia </li></ul></ul>
  22. 22. <ul><li>Alternative to sclerotherapy </li></ul><ul><li>Fewer rebleeding episodes </li></ul><ul><li>Fewer endoscopic interventions </li></ul><ul><li>Lower procedure related mortality and over all mortality </li></ul>Band Ligation
  23. 23. Pharmacologic versus Endoscopic Therapy <ul><li>2 meta-analysis compared medical pharmacotherapy with emergency sclerotherapy as 1 st line treatment for acute bleeding: </li></ul><ul><ul><li>No significant difference regarding initial hge control or mortality </li></ul></ul><ul><ul><li>Administration of somatostatin before and after sclerotherapy : </li></ul></ul><ul><ul><ul><li>Improve treatment efficacy </li></ul></ul></ul><ul><ul><ul><li>Reduce blood transfusion </li></ul></ul></ul>
  24. 24. Balloon Temponade <ul><li>Application of direct upward pressure against varices at G-E junction </li></ul><ul><li>Should be intubated: </li></ul><ul><ul><li>Prevent aspiration </li></ul></ul><ul><ul><li>Prevent airway occlusion </li></ul></ul>
  25. 25. Balloon positioning
  26. 26. <ul><ul><li>1. Tube inserted to 50 cm </li></ul></ul><ul><ul><li>2. Auscultate in stomach </li></ul></ul><ul><ul><li>3. Inflate gastric balloon with 50 cc </li></ul></ul><ul><ul><li>4. Stat portable film </li></ul></ul><ul><li>Re-confirm proximal position </li></ul><ul><li>Inflate GB 300-400 cc air </li></ul><ul><li>Pull to insure anchorage </li></ul><ul><li>Recheck film </li></ul><ul><li>1-2 lbs of pully traction </li></ul>Tube Positioning and Gastric Balloon Inflation
  27. 27. <ul><li>Esophageal Balloon inflated to 35 - 40 mmHg </li></ul><ul><li>Last resort </li></ul><ul><li>Deflate periodically </li></ul><ul><li>Use minimum effective pressure </li></ul><ul><li>Complication </li></ul><ul><li>- ulcer </li></ul><ul><li>- perforation </li></ul><ul><li>- stricture </li></ul>Gastric and Esophageal Balloon Inflation
  28. 28. <ul><li>Direct temponade therapy is 90% effective in controlling the bleeding </li></ul><ul><li>50% rebleeding after removal </li></ul><ul><li>Serious potential complications (mortality 20%) </li></ul><ul><li>Bridge therapy </li></ul>
  29. 29. TIPS (Transjagular Intrahepatic Portosystemic Shunting) <ul><li>Creating an intrahepatic portosystemic fistula to decompress the portal hypertension </li></ul><ul><li>First performed in 1982 </li></ul><ul><li>(non- selective side to side portosystemic shunt) </li></ul>
  30. 30. <ul><li>1 -Cannulating the Rt hepatic vein via internal jagular vein </li></ul><ul><li>2 – passing needle through liver parenchyma to portal vein branch </li></ul><ul><li>3- guide wire </li></ul><ul><li>4 balloon dilatation </li></ul>
  31. 31. <ul><li>5 – stenting the tract </li></ul>
  32. 33. <ul><li>Meta-analysis comparing TIPS with endoscopy in acute hge: </li></ul><ul><ul><li>Significant improvement in controlling the hge </li></ul></ul><ul><ul><li>Coast : ↑rate of hepatic encephalopathy </li></ul></ul>
  33. 34. <ul><li>Contraindications: </li></ul><ul><ul><li>R side heart failure </li></ul></ul><ul><ul><li>Polycystic liver </li></ul></ul><ul><ul><li>Portal vein thrombosis </li></ul></ul>
  34. 35. <ul><li>Complications: </li></ul><ul><ul><li>Intraperitoneal bleeding due to perforation of the hepatic capsule, hepatic, or portal veins </li></ul></ul><ul><ul><li>TIPS embolization </li></ul></ul><ul><ul><li>Acute right heart failure due to increased venous return to right heart </li></ul></ul>
  35. 36. <ul><li>Late: </li></ul><ul><ul><li>recurrent bleeding due to TIPS stenosis or thrombosis </li></ul></ul><ul><ul><li>Infection </li></ul></ul><ul><ul><li>hepatic encephalopathy. </li></ul></ul>
  36. 37. Surgical Therapy <ul><li>Operative intervention is reserved for cases refractory to other modalities </li></ul>
  37. 38. <ul><li>Esophageal transection EEA stapler </li></ul><ul><ul><li>Operative mortality 75% </li></ul></ul><ul><ul><li>Complications 25%: </li></ul></ul><ul><ul><ul><li>Perforation </li></ul></ul></ul><ul><ul><ul><li>Stricture </li></ul></ul></ul><ul><ul><ul><li>Esophagitis </li></ul></ul></ul><ul><ul><ul><li>-> not useful in acute state </li></ul></ul></ul>
  38. 39. <ul><li>Portosystemic Shunt (side-to-side) </li></ul><ul><ul><li>Non-selective shunt </li></ul></ul><ul><ul><li>Manipulation and dissection in porta hepatica -> </li></ul></ul><ul><ul><li>Scaring and fibrosis -> complicate future liver transplant </li></ul></ul>
  39. 40. <ul><li>DSRS </li></ul><ul><ul><li>Selective shunt </li></ul></ul><ul><ul><li>Some cases un accompanied by refractory ascitis </li></ul></ul>
  40. 41. Prevention of Recurrent Variceal Bleeding
  41. 42. <ul><li>Pharmacotherapy: </li></ul><ul><ul><li>Rebleeding without treatment 70% in 1 year </li></ul></ul><ul><ul><li>Non-selective B blockers (propranalol) </li></ul></ul><ul><ul><li>↓ portal pressure </li></ul></ul><ul><ul><li>Effect is variable and unpredictable </li></ul></ul><ul><ul><li>Less benefit with decompesated liver </li></ul></ul>
  42. 43. <ul><li>Endoscopic therapy: </li></ul><ul><ul><li>Advocated as a means for complete eradication of esophageal varices </li></ul></ul><ul><ul><li>Once eliminated routine endoscopy 6-12 months </li></ul></ul><ul><ul><li>Fewer rebleeding episodes than medical treatment </li></ul></ul><ul><ul><li>50 % rebleding in 1 year </li></ul></ul><ul><ul><li>30% need conversion </li></ul></ul><ul><ul><li>Reserved for complaint patients </li></ul></ul>
  43. 44. <ul><li>TIPS: </li></ul><ul><ul><li>Bridge therapy -> liver transplant </li></ul></ul><ul><li>Advantiges over surgery: </li></ul><ul><ul><li>No risk of general anesthesia </li></ul></ul><ul><ul><li>No post-operative complications </li></ul></ul><ul><li>Limitations </li></ul><ul><ul><li>Stenosis (50% in 1 st year) </li></ul></ul><ul><ul><li>Encephalopathy (1/3) </li></ul></ul>
  44. 45. <ul><li>Surgical Therapy: </li></ul><ul><ul><li>Most effective method in controlling portal hypertension and recurrent bleeding </li></ul></ul><ul><ul><li>1 Portosystemic shunt procedures </li></ul></ul><ul><ul><li>2 Esophagogastric devascularization </li></ul></ul><ul><ul><li>3 Orthotopic liver transplantation </li></ul></ul>
  45. 46. Portosystemic Shunt <ul><li>Decompressing the hypertensive portal Venus system into the low pressure systemic venous circulation </li></ul><ul><li>Toxins -> systemic circulation -> encephalopathy </li></ul>
  46. 47. <ul><li>To minimize these effects shunting operations have evolved: </li></ul><ul><ul><li>Non-selective </li></ul></ul><ul><ul><li>Selective </li></ul></ul><ul><ul><li>partial </li></ul></ul>
  47. 48. 1 – Non selective Shunts <ul><li>End to side portocaval (Eck fistula): </li></ul><ul><ul><li>Higher rate of encephalopathy among operative shunting groups </li></ul></ul><ul><ul><li>Better control of rebleeding than medical treatment </li></ul></ul><ul><ul><li>Eck fistula – medical therapy -> same incidence of encephalopathy </li></ul></ul>
  48. 49. <ul><li>Side to Side portocaval shunt: </li></ul><ul><ul><li>Maintain the anatomic continuity of the portal vein </li></ul></ul><ul><ul><li>Encephalopathy rate : no difference </li></ul></ul><ul><ul><li>Decompress the sinusoidal pressure -> better ascitis control </li></ul></ul><ul><ul><li>Recommended for Budd Chiari Syndrome </li></ul></ul><ul><ul><li>More difficult than end to side </li></ul></ul>
  49. 50. <ul><li>Interposition Mesocaval Shunt: </li></ul><ul><ul><li>Prosthetic – autogennous vien </li></ul></ul><ul><ul><li>Avoid hilar dissection (future transplant) </li></ul></ul><ul><ul><li>Shunt ligation in refractory post-op encephalopathy </li></ul></ul><ul><ul><li>Drawback -> thrombosis (35%) </li></ul></ul>
  50. 51. <ul><li>Proximal Spleno-Renal Shunt: </li></ul><ul><ul><li>Splenectomy + anastomosing proximal Splenic vein to Lt Renal vein </li></ul></ul><ul><ul><li>Divert all portal flow into renal vein -> non selective </li></ul></ul><ul><ul><li>Shunt occlusion 18% </li></ul></ul>
  51. 52. 2 – Selective Shunts <ul><li>In response to post-op complications of non-selective procedures </li></ul><ul><li>1967 DSRS </li></ul><ul><li>Distal Splenic vein to Lt renal Vein </li></ul><ul><li>Selectively decompress the esophagogastric veins </li></ul>
  52. 53. <ul><li>Contraindications: </li></ul><ul><ul><li>Refractory ascitis </li></ul></ul><ul><ul><li>Splenic vein thrombosis </li></ul></ul><ul><ul><li>Previously underwent splenectomy </li></ul></ul><ul><ul><li>Splenic vein diameter < 7 mm </li></ul></ul>
  53. 54. <ul><li>Coronary – Caval Shunt: </li></ul><ul><ul><li>Described in Japan in 1984 </li></ul></ul><ul><ul><li>Interposition graft between L Gastric and inferior vena cava </li></ul></ul><ul><ul><li>Little experience with this procedure </li></ul></ul>
  54. 55. 3 – Partial Shunts <ul><li>Small diameter interposition grafts </li></ul><ul><li>Maintaining a degree of hepatopedal portal flow to the liver </li></ul>
  55. 56. Esophagogastric Devascularization <ul><li>The most effective non-shunt operation for preventing variceal bleeding: </li></ul><ul><ul><li>Devascularization + transection + splenectomy </li></ul></ul><ul><ul><li>Sugiura procedure </li></ul></ul>
  56. 57. Orthotopic Liver Transplantation <ul><li>The most definitive form of therapy for complications of portal hypertension </li></ul><ul><li>Selective patients: </li></ul><ul><ul><li>Coast </li></ul></ul><ul><ul><li>Unavailability </li></ul></ul><ul><ul><li>Immunosuppresion </li></ul></ul>
  57. 58. <ul><li>Child A – mild B -> non-transplant surgery </li></ul><ul><li>Child C – advanced B -> transplant </li></ul>
  58. 59. Prophylaxis
  59. 60. <ul><li>Likehood of variceal bleeding : </li></ul><ul><ul><li>Alcoholic cirrhosis </li></ul></ul><ul><ul><li>Active alcohol consumption </li></ul></ul><ul><ul><li>Sever hepatic dysfunction </li></ul></ul><ul><ul><li>Endoscopy: </li></ul></ul><ul><ul><ul><li>Variceal wall thinning </li></ul></ul></ul><ul><ul><ul><li>Variceal tortuosity </li></ul></ul></ul><ul><ul><ul><li>Superimposition of varices on other </li></ul></ul></ul><ul><ul><ul><li>Gastric varicose </li></ul></ul></ul>
  60. 61. <ul><li>Non selective B blockers </li></ul><ul><li>Prophylactic shunts showed no benefit , ↑morbidity </li></ul>
  61. 62. <ul><li>Portal hypertension in north Indian children </li></ul><ul><li>Arora NK, Lodha R, Gulati S, Gupta AK, Mathur P, Joshi MS, Arora N, Mitra DK </li></ul><ul><li>Department of Paediatrics </li></ul><ul><li>All India Institute of Medical Sciences </li></ul><ul><li>New Delhi. </li></ul>
  62. 63. <ul><li>cross-sectional observational study </li></ul><ul><li>Tertiary care centre in northern India </li></ul><ul><li>January, 1990 to December, 1994 </li></ul><ul><li>Children below the age of 14 years with suspected portal hypertension </li></ul><ul><li>To determine the etiology and clinical profile of portal hypertension </li></ul>
  63. 64. <ul><li>115 patients with portal hypertension </li></ul><ul><ul><li>76.5% had extrahepatic portal hypertension (EHPH) </li></ul></ul><ul><ul><li>23.5% had intrahepatic causes of portal hypertension </li></ul></ul>
  64. 65. <ul><li>Results: </li></ul><ul><ul><li>Children with EHPH had a significantly earlier onset of symptoms as compared to those with intrahepatic portal hypertension (p = 0.002) </li></ul></ul><ul><ul><li>And bled significantly more frequently (p = 0.00). </li></ul></ul>
  65. 66. <ul><li>History suggestive of potential etiological factors could be elicited in only 7% of EHPH patients . </li></ul><ul><li>The commonest site of block in splenoportal axis was at the formation of the portal vein . </li></ul>
  66. 67. <ul><li>An inverse relation of bleeding rates with duration of illness was seen in EHPH </li></ul>
  67. 68. <ul><li>Conclusion: </li></ul><ul><ul><li>Understanding the natural history of EHPH and portal hypertension due to other etiologies may have significant implications in choosing the appropriate intervention and predicting the outcome . </li></ul></ul>
  68. 69. <ul><li>References </li></ul><ul><ul><li>ACS Surgery : Principles and Practice 2004 Web,MD </li></ul></ul><ul><ul><li>Schwartz Principles of Surgery 7 th Edition </li></ul></ul><ul><ul><li>Indian J Pediatr. 1998 Jul-Aug;65(4):585-91. </li></ul></ul><ul><ul><li>Johns Hopkins Gastroenterology & Hepatology Resource Center http://hopkins-gi.nts.jhu.edu </li></ul></ul>
  69. 70. <ul><li>Thank You </li></ul>

×